Europe's equity story today splits sharply between a big-picture contrarian call and stock-specific action in Germany.
On the index level, one camp of analysts is pushing a valuation-driven "short US, long UK" trade over the coming months. The argument: stretched US tech and AI expectations leave American equities exposed, while UK valuations look cheap enough to serve as a hedge. It's a minority view, but it's the clearest directional index call in circulation.
At the single-stock level, researchers highlight a rotation into commodity-linked German names. ThyssenKrupp is drawing outsized demand on fresh analyst upgrades, with Salzgitter and Aurubis riding the same resource-sector wave.
The outlier is Fielmann, which published views expect to open sharply lower after softer operating profit and margins — a read-through on weak German consumer sentiment, with full earnings due next Thursday as the next catalyst.
Elsewhere, a planned sale of a 2.9% Fresenius Medical Care stake is framed as a positive for Fresenius at the open, and a short-term drag on FMC itself.